• 13+ Years of Experience
• 5+ Team Members
• 100% Satisfied Clients

Who We Are:

Leading the Charge in Real-World Evidence Strategy and Advisory

MEDDDICAL provides expert guidance that has accelerated drug development and market access strategies for numerous clients, demonstrating a commitment to driving impactful healthcare solutions.

At MEDDDICAL, we’ve successfully transformed the approach to drug development by helping pharmaceutical companies navigate the complex landscape of real-world evidence. Our clients have reported increased efficiency in market access strategies and improved understanding of patient cohorts — ultimately resulting in better healthcare outcomes. The gap between identifying the right data strategy and executing it effectively is where our expertise makes the difference.

Our Journey:

A Legacy of Innovation in Healthcare Data Strategy

Founded to bridge the gap in real-world evidence, MEDDDICAL began its journey by pioneering expert advisory services for pharmaceutical companies navigating aggregated data analytics. Over the years, our capabilities have evolved, adapting to the shifting needs of the industry and delivering strategic insights that facilitate better decision-making and patient outcomes.

Our multi-professional team combines specialists from health economics, statistics, and data science — giving us the depth to assess not just what data exists, but which approaches genuinely serve your specific objectives. The challenge most pharmaceutical companies face isn’t awareness that real-world evidence matters. It’s knowing which data strategy, which analytical approach, and which partnerships will actually move their programs forward. That’s where we come in.